1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Wesana Health Holdings Inc.
  6. Company
    WESA   CA95081C1059

WESANA HEALTH HOLDINGS INC.

(WESA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  01:18 2022-06-30 pm EDT
0.1850 CAD   +2.78%
06/08WESANA HEALTH CEO DANIEL CARCILLO TO KEYNOTE CHARLES RIVER SYMPOSIUM : Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairman
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Wesana Health Holdings Inc is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain Injury related depressive disorder, anxiety and migraines through drug development and predictive diagnostics. The Company is also engaged in care development through its therapies and patent-pending protocols, and in care delivery through activating a multidisciplinary, technology-supported clinical model. Its SANA-013 is a novel composition and method of use that provides sustained effects and benefit over time. The Company’s novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen of a micro dose of psilocybin combined with cannabidiol, significantly reduced depressive behaviors in a validated animal model.
Sales per Business
2021
Psychedelic and Naturally-sourced Therapies0.50100%
CAD in Million
Sales per region
20202021Delta
Canada--0.50100%-
CAD in Million
Managers
Name Title Age Since
Daniel Carcillo Chief Executive Officer & Director - -
Zed Wang Chief Financial Officer & Secretary 32 -
Mark Wingertzahn, Dr. Chief Scientific Officer 50 2021
Keenan Gentry VP-Investor Relations & Corporate Development - 2021
Meghna A. Gaeta Chief Marketing Officer - 2022
Members of the board
Name Title Age Since
Chad Bronstein Executive Chairman 33 -
Daniel Carcillo Chief Executive Officer & Director - -
Mitchell Kahn Director 60 -
Robert Koffman, Dr. Director - -
George Michael Steinbrenner Director 24 -
Ian Burnstein Director 51 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,228,689 19,049,586 99.1% 0 0.0% 99.1%
Shareholders
NameEquities%
K2 & Associates Investment Management, Inc. 2,837,565 14.4%
James Gregory Wilson 211,701 1.08%
Jason I Goldman 211,701 1.08%
Chad Bronstein 195,000 0.99%
Daniel Carcillo 134,418 0.68%
Marc Lustig 105,851 0.54%
Rajiv Bhatia 105,851 0.54%
George Michael Steinbrenner 71,428 0.36%
Ian Burnstein 69,600 0.35%
Hayim Daniel Raclaw 32,218 0.16%
Holdings
NameEquities%Valuation
WESANA HEALTH HOLDINGS INC. (WESA) 3,900 0.020% 640 USD
Brand Portfolio
In partnership withAllbrands.markets
More brands of Wesana Health Holdings Inc.